Welcome To Ethinova
Founded in 2026 by Dr.Raouf Hajji, Assistant Professor of Medicine and Healthtech consultant with 14 years experience.
ETHINOVA supports HealthTech founders worldwide: from idea to final product, with clinical insight at every stage.
A global advisory hub built on ethics, clinical reality, and the discipline of getting HealthTech right.
The Problem
The difference between tech and HealthTech?
One serves users.
The other saves lives.
Most HealthTech founders don't fail because their technology is weak.
They fail because clinical insight, ethical grounding, and market access were treated as afterthoughts.
ETHINOVA exists to change that.
Why Ethinova
Ethics is not a marketing layer. It's the architecture.
Grounded in Maqasid al-Shariah, where the preservation of life and the trust of stewardship are operational standards, not abstract ideals.
Combined with global market fluency, clinical depth, and cross-border innovation experience.
For founders, this means clinical insight and ethical grounding become your competitive advantage, with investors, clinicians, regulators, and the patients who ultimately decide whether your product earns their trust.
Who We Work With
ETHINOVA works with one kind of person: the HealthTech founder.
Clinician-founders
translating bedside insight into digital health ventures
Technical founders
building clinical or AI-driven health solutions
Non-clinical founders
entering HealthTech who need clinical grounding
Early-stage founders
shaping idea, MVP, and first clinical partnerships
Pre-Launch Founders
finalizing product, regulatory and go-to-market readiness before market entry.
Growth-stage founders
preparing to raise, enter new markets, or scale responsibly
Built For Founders. Built For The World
Healthcare doesn't respect borders. Neither does the patient at the center of every HealthTech product.
ETHINOVA works with founders wherever they're building, because the problems worth solving in HealthTech are universal, and the standards for solving them should be too. Whether your venture is designed for a single health system or a global market, the clinical insight and ethical framework that make it credible remain the same.
One founder. One patient. One standard. Worldwide.
FOUNDER-LED. CLINICALLY GROUNDED. GLOBALLY EXPERIENCED.
ETHINOVA is led by a physician-researcher and International HealthTech Consultant with 300+ HealthTech consultations delivered to founders worldwide.
✔️ Co-founder and Medical Lead, International Medical Community (IMC): HealthTech Hub
✔️ Former Chief Academic Officer at Supernova Academy Inc.
✔️ 300+ HealthTech consultations delivered globally
✔️ 6 + MIT hackathon mentor since 2019
✔️ 2 + EUvsVirus Hackathon mentor
✔️ French Hackathon
✔️ Contributor to HealthTech startups and an NGO
✔️ Advisor to founders across global innovation ecosystems
Testimonials & Results
SWIPE FOR THE NEXT TETIMONIAL
Our discussion regarding research transition from pure medicine to medical engineering helped clarify several sticking points in my future projects. I particularly appreciated the suggestion of continuing work within the interested specialty of medicine as an engineer and have given me more confidence to pursue more.
Dr. Raouf is a very smart man, who can relate in all level, he is also ready to help you build..He give premium attention
Dr Raouf is one of the amazing professionals that I get the chance to work with , His deep knowledge in the healthtech Sector and biomedical industry make him one of the rare specialist that can guide you through establishing the right vision for the product.
This session aims to provide a clear, realistic, and educational understanding of health care management, viewed directly through the lens of a medical doctor. It goes beyond clinical practice to explore how medical decisions interact with management, organization, and system-level constraints.
Working with Dr Raouf was a genuinely valuable experience. He brings sharp, structured thinking and a calm, practical approach to complex problems. His questions pushed me to test assumptions, weigh real-world constraints, and keep impact for underserved groups at the centre. I’d happily collaborate with him again.